These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28432666)

  • 1. Optimizing myocardial metabolism for fluorine-18 fluorodeoxyglucose positron emission tomography imaging of cardiac inflammation.
    Andrikopoulou E; Bhambhvani P
    J Nucl Cardiol; 2018 Aug; 25(4):1372-1375. PubMed ID: 28432666
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of prolonged fasting and low molecular weight heparin or warfarin therapies on 2-deoxy-2-[18F]-fluoro-D-glucose PET cardiac uptake.
    Giorgetti A; Marras G; Genovesi D; Filidei E; Bottoni A; Mangione M; Emdin M; Marzullo P
    J Nucl Cardiol; 2018 Aug; 25(4):1364-1371. PubMed ID: 28160263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.
    Osborne MT; Hulten EA; Murthy VL; Skali H; Taqueti VR; Dorbala S; DiCarli MF; Blankstein R
    J Nucl Cardiol; 2017 Feb; 24(1):86-99. PubMed ID: 27277502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron Emission Tomography Fluorine-18-Labeled 2-Deoxy-2-Fluoro-d-Glucose Tells a Complicated Story in the Aortic Aneurysm Wall.
    Curci JA; Beckman JA
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903546
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute myeloid leukemia detected on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in a patient with fever of unknown origin.
    Ozcan Kara P; Kara Gedik G; Sari O; Serdengecti M; Kaya B
    Rev Esp Med Nucl; 2011; 30(2):115-6. PubMed ID: 21316125
    [No Abstract]   [Full Text] [Related]  

  • 6. [(18)F-fluorodeoxyglucose positron emission tomography/computed tomography and unknown origin primary tumor. Current usefulness and future perspectives].
    Duch J
    Med Clin (Barc); 2013 Jan; 140(1):22-3. PubMed ID: 23122613
    [No Abstract]   [Full Text] [Related]  

  • 7. Performance of fluorodeoxyglucose-positron-emission tomography/computed tomography for evaluating tumor response to nonsurgical treatment.
    Ishihara K; Kobayashi Y; Iwano M; Shiiba M; Yoshihara H; Satoh H; Akiyama K; Kumita S
    J Nippon Med Sch; 2011; 78(5):272-3. PubMed ID: 22041872
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular imaging of the atherosclerotic plaque using positron emission tomography.
    Toor IS; Dweck MR; Newby DE
    J R Coll Physicians Edinb; 2014; 44(2):139-45. PubMed ID: 24999778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the duration of fasting on myocardial fluorine-18-fluorodeoxyglucose positron emission tomography images in normal males.
    Yamanouchi M; Yoshida K; Niwayama H; Nakagawa K; Aioi S; Shikama N; Himi T; Imazeki K; Itoh Y; Masuda Y
    Jpn Circ J; 1996 Jun; 60(6):319-27. PubMed ID: 8844297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography.
    Hicks RJ; Herman WH; Kalff V; Molina E; Wolfe ER; Hutchins G; Schwaiger M
    J Am Coll Cardiol; 1991 Jul; 18(1):101-11. PubMed ID: 2050912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Imaging of Atheroma: Deciphering How and When to Use
    Tawakol A; Osborne MT; Fayad ZA
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):. PubMed ID: 28292862
    [No Abstract]   [Full Text] [Related]  

  • 12. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
    Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic Intracranial Recurrence of Olfactory Neuroblastoma without Accumulation on Fluorine-18-fluorodeoxyglucose Positron Emission Tomography.
    Ishi Y; Yamaguchi S; Hatanaka KC; Takakuwa E; Motegi H; Honda T; Kobayashi H; Terasaka S; Homma A; Fujimura M; Houkin K
    Acta Med Okayama; 2022 Feb; 76(1):93-98. PubMed ID: 35237005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodology governing the assessment of myocardial glucose metabolism by positron emission tomography and fluorine 18-labeled fluorodeoxyglucose.
    Gropler RJ
    J Nucl Cardiol; 1994; 1(2 Pt 2):S4-14. PubMed ID: 9420692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.
    Choi Y; Brunken RC; Hawkins RA; Huang SC; Buxton DB; Hoh CK; Phelps ME; Schelbert HR
    Eur J Nucl Med; 1993 Apr; 20(4):308-18. PubMed ID: 8491223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Images in cardiovascular medicine. Cardiac metastasis: visualization with positron emission tomography, computed tomography, magnetic resonance imaging, positron emission tomography/computed tomography, and positron emission tomography/magnetic resonance imaging.
    Seemann MD; Gaa J
    Circulation; 2005 Nov; 112(21):e329-30. PubMed ID: 16301348
    [No Abstract]   [Full Text] [Related]  

  • 17. How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT.
    Maurer AH; Burshteyn M; Adler LP; Steiner RM
    Radiographics; 2011; 31(5):1287-305. PubMed ID: 21918045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can fluorine-18 fluoroestradiol positron emission tomography-computed tomography demonstrate the heterogeneity of breast cancer in vivo?
    Yang Z; Sun Y; Zhang Y; Xue J; Wang M; Shi W; Zhu B; Hu S; Yao Z; Pan H; Zhang Y
    Clin Breast Cancer; 2013 Oct; 13(5):359-63. PubMed ID: 23787040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically relevant strategies for lowering cardiomyocyte glucose uptake for 18F-FDG imaging of myocardial inflammation in mice.
    Thackeray JT; Bankstahl JP; Wang Y; Wollert KC; Bengel FM
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):771-80. PubMed ID: 25389013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.